Dear Reader,
Welcome to the first issue of 2026. As we step into a new year, we also step into new frontiers of medical science and patient care.
In our Feature Story, we explore how lipid management for cardiovascular disease (CVD) prevention is entering a transformative phase. Two converging trends are reshaping the field: earlier intervention—guided by the principle “the earlier, the better”—and broader strategies that address residual risk beyond low-density lipoprotein cholesterol (LDL-C). Together, these approaches signal a more proactive and comprehensive era in cardiovascular health.
Our Focus Section turns to World Cancer Day, observed annually on 4 February. The 2025–2027 theme, “United by Unique,” calls for a fundamental shift in how cancer care is understood and delivered. It challenges us to move from systems built around diseases to systems designed around people—recognizing individuality as the cornerstone of progress in oncology.
In Industry Update, we spotlight key developments across multiple therapeutic areas:
• Dyslipidemia Management – Insights from the 2025 update of the 2019 ESC/EAS Guidelines, optimizing the therapeutic landscape.
• Migraine Care – How CGRP treatments have exceeded trial expectations, offering optimism for the future while underscoring the importance of tolerability for patients.
• Hematology Spotlight – 1) The emerging role of Zanubrutinib in countering follicular lymphoma; 2) Exploring pathways toward curing Hodgkin’s lymphoma and empowering patients to thrive fearlessly in the years ahead.
As always, our mission is to bring you timely, thoughtful, and clinically relevant perspectives that illuminate the evolving landscape of medicine. May this issue inspire reflection, spark dialogue, and strengthen our shared commitment to advancing patient-centered care.
Warm regards,
Dr. Feng Xue
MPH, PhD
Managing Editor, V.Pulse
To provide articles that match your interest, a V∙Pulse Reader Survey has been launched to collect your opinions on the preferred topics.
